Cargando…
Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis
Metformin has garnered considerable interest as a chemo-preventive and chemo-therapeutic agent given the increased risk of liver cancer among diabetic patients. This work was performed to illustrate the association between metformin use and survival of diabetic liver cancer patients. We conducted a...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323227/ https://www.ncbi.nlm.nih.gov/pubmed/27494848 http://dx.doi.org/10.18632/oncotarget.11033 |